https://www.selleckchem.com/pr....oducts/trastuzumab.h
For patients with aright or left coronary artery originating from the pulmonary artery and coronary arteriovenous fistulas aregistry is maintained. Primary outcomes are (cardiac) death, myocardial ischaemia attributable to the ACAOS, re-intervention after surgery and intervention after initially conservative treatment. The influence of work-up examinations on treatment choice is also evaluated. Structural evidence for the appropriate management of patients with coronary anomalies, especially (interarterial) ACAOS, is lacking. By mea